Chi, Jhih-Ying <br/><br/>
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.  [electronic resource] 

 -  Oncotarget  Sep 2015 
 - 23987-4001 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4364  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Apoptosis--drug effects<br/>C-Reactive Protein--antagonists & inhibitors<br/>CCAAT-Enhancer-Binding Protein-delta--metabolism<br/>Cell Line, Tumor<br/>Cell Movement<br/>Cell Survival<br/>Cell Transformation, Neoplastic--genetics<br/>Cisplatin--chemistry<br/>Culture Media, Conditioned--chemistry<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fibroblasts--drug effects<br/>Fluorouracil--chemistry<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Myofibroblasts--drug effects<br/>Neoplasm Invasiveness<br/>Neoplasm Metastasis<br/>Neoplasm Transplantation<br/>Neoplasms--metabolism<br/>Peptide Fragments--chemistry<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Serum Amyloid P-Component--antagonists & inhibitors<br/>Tumor Microenvironment--drug effects